申请人:LG CHEM, LTD.
公开号:US10322135B2
公开(公告)日:2019-06-18
The present invention relates to a pharmaceutical composition comprising a compound of formula (1), (2) or (3) as defined in the specification for the prevention or treatment of diseases associated with oxidative stress, mitochondria dysfunction, hypoxic injury, necrosis and/or ischemic reperfusion injury, and a cosmetic composition comprising an indole compound having an antioxidant effect.
本发明涉及一种药物组合物,该药物组合物包含说明书中定义的式(1)、(2)或(3)化合物,用于预防或治疗与氧化应激、线粒体功能障碍、缺氧损伤、坏死和/或缺血再灌注损伤相关的疾病,以及一种化妆品组合物,该化妆品组合物包含具有抗氧化作用的吲哚化合物。